UBE2S can promote the progression of many types of cancer, such as ovarian cancer (Hu et al., 2021), non-small cell lung cancer (Qin et al., 2020), colorectal cancer (Li et al., 2018) and prostate cancer (Peng et al., 2022). Here, UBE2S is linked to ovarian carcinoma.